Patents by Inventor Kyeong-Han PARK

Kyeong-Han PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240174847
    Abstract: A polypropylene composite resin composition and a molded article including the polypropylene composite resin composition are disclosed. In certain examples, the polypropylene composite resin composition includes an improved elongation and impact strength. The polypropylene composite resin composition may include a first polypropylene copolymer having a melt flow index in a range of 30 g/10 min to 150 g/10 min (230° C., 2.16 kg), a second polypropylene copolymer having a melt flow index in a range of 1 g/10 min to 20 g/10 min (230° C., 2.16 kg), an impact modifier having a Mooney viscosity (ML1+4, 125° C.) in a range of 10 to 70, a dye, and an additive in appropriate amounts.
    Type: Application
    Filed: June 30, 2023
    Publication date: May 30, 2024
    Applicants: HYUNDAI MOTOR COMPANY, KIA CORPORATION, HDC HYUNDAI ENGINEERING PLASTICS CO., LTD.
    Inventors: In Soo Han, Eun Ju Noh, Seul Yi, Kyeong Hoon Jang, Ju Seong Park, Jin Bo Chae, Eun Seob Shin
  • Patent number: 9493528
    Abstract: Provided are small peptide fragments derived from microphthalmia-associated transcription factor (MITF) and a method for preventing or treating melanoma using the same as an active ingredient. Further provided is a method for skin-whitening and/or for inhibiting skin pigmentation, using the peptide fragments as an active ingredient.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: November 15, 2016
    Assignees: SUPADELIXIR INC., KNU-INDUSTRY COOPERATION FOUNDATION
    Inventors: Kyeong-Han Park, Jang-Hee Hahn, Dong-Young Lim
  • Publication number: 20160002308
    Abstract: The present invention provides small peptide fragments derived from microphthalmia-associated transcription factor (MITF) and a pharmaceutical composition for preventing or treating melanoma comprising the same as an active ingredient. And also, the present invention provides a cosmetic composition for skin-whitening and/or for inhibiting skin pigmentation, comprising the peptide fragments as an active ingredient.
    Type: Application
    Filed: January 7, 2014
    Publication date: January 7, 2016
    Applicants: SUPADELIXIR INC., KNU-INDUSTRY COOPERATION FOUNDATION
    Inventors: Kyeong-Han PARK, Jang-Hee HAHN, Dong-Young LIM